◆ NeutralICCM
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
Benzinga·
IceCure Medical Ltd. (NASDAQ: ICCM) announced a $5.5 million private placement of 1.83 million ordinary shares and warrants priced at $3.00 per share, representing a premium to the previous closing price. The offering is expected to close on June 18, 2026, with proceeds intended for working capital and general corporate purposes. The company also agreed to amend previously issued warrants to reduce their exercise price from $16.50 to $3.00 per share, subject to shareholder approval.
Read Full Article at Benzinga →